Authors: Terry L. Schwinghammer (Editor), Julia M. Koehler
ISBN-13: 9780071488358, ISBN-10: 0071488359
Format: Paperback
Publisher: McGraw-Hill Companies, The
Date Published: July 2008
Edition: 7th Edition
Terry L. Schwinghammer, PharmD, FCCP, FASHP, BCPS, Professor and Chair, Department of Clinical Pharmacy, West Virginia University School of Pharmacy, Morgantown, WV
Julia M. Koehler, PharmD, Associate Professor and Chair, Department of Pharmacy Practice, Butler University, College of Pharmacy and Health Sciences; and Clinical Pharmacist in Family Medicine, Methodist Hospital and the Indiana University-Methodist Family Practice Center, Clarian Health Partners, Indianapolis, IN
Pharmacotherapy Casebook is the perfect working tool to help students develop the essential skills required to identify and resolve drug therapy problems. Using a consistent, problem-solving approach, this new edition helps readers enhance their pharmacotherapeutic skills.
The authors include updated and revised patient cases involving 145 disease states. Sixteen new disease states have been added to this edition, along with a new chapter on Pharmaceutical Care Plans. Each case includes a realistic patient presentation with medical history, physical examination, and laboratory data followed by a series of questions employing a systematic, problem-solving approach. By using these real world cases to practice creating, defending, and implementing pharmaceutical care plans, students can develop the skills necessary to make the critical decisions required in their practice.
Organized into organ system sections that correspond to Pharmacotherapy: A Pathophysiologic Approach, 5e, this authoritative casebook is an outstanding learning tool for educational programs. It is also a valuable resource for independent study and staff development.
FEATURES:
* Draws upon the expertise of 170 authors from across the U.S. and Canada
* Presents an individualized therapeutic approach to disease state management
* Employs a consistent problem-solving approach that provides practice in creating, defending, and implementing pharmaceutical care plans
* Provides three levels of case complexity that correspond to different experience levels of students
* Contains Appendices with reference ranges for common laboratory tests, common medical abbreviations, and sample responses to case questions
* NEW TO THIS EDITION: Each case has been revised and 16 completely new disease states have been added; includes cases and a separate section that contain questions related to herbal therapies.
This is a collection of patient case studies involving a broad spectrum of disease states. It is intended to complement the information presented in the fourth edition of Dipiro's Pharmacotherapy: A Pathophysiologic Approach (Appleton & Lange, 1999). The editor's purpose is to aid students in healthcare fields in the development of patient care related skills involving the identification and resolution of medication-related problems through the use of patient care studies. The target audience is pharmacy educators and pharmacy students; however, it may be a useful learning tool for all healthcare professionals. In Part One the following information is outlined: how to use the casebook; active learning strategies; case studies in patient communication; and documentation of pharmacist interventions. The remaining portion of the casebook is divided into the following sections: disorders of organ systems; diseases of infectious origin; oncologic disorders; and nutrition and nutritional disorders. Patient case studies begin with patient presentation, which mimics what is found in a typical patient chart. A series of questions for the student follow the case presentation, and a list of useful references. This casebook is a beneficial extension to the fourth edition of Pharmacotherapy: A Pathophysiologic Approach, in that the editor encourages students to apply newly learned information to clinical scenarios. References listed following each patient case study direct students to additional information, which may be useful in answering questions. Overall, this reference is a useful tool for teaching students the pharmacotherapeutic approach to patient care,which involves the designing, implementing, and monitoring of a drug therapy regimen.
Ch. 1 | Introduction : how to use this casebook | 1 |
Ch. 2 | Active learning strategies | 9 |
Ch. 3 | Case studies in patient communication | 13 |
Ch. 4 | Care planning : a component of the patient care process | 25 |
Ch. 5 | Documentation of pharmacist interventions | 33 |
Ch. 6 | Cardiopulmonary resuscitation | 39 |
Ch. 7 | Hypertension | 42 |
Ch. 8 | Obstructive sleep apnea and hypertension | 45 |
Ch. 9 | Hypertensive urgency/emergency | 47 |
Ch. 10 | Heart failure | 49 |
Ch. 11 | Ischemic heart disease and acute coronary syndrome | 53 |
Ch. 12 | Acute myocardial infarction | 56 |
Ch. 13 | Ventricular tachycardia | 58 |
Ch. 14 | Atrial fibrillation | 61 |
Ch. 15 | Hypertrophic cardiomyopathy | 63 |
Ch. 16 | Deep vein thrombosis | 65 |
Ch. 17 | Pulmonary embolism | 68 |
Ch. 18 | Chronic anticoagulation | 72 |
Ch. 19 | Ischemic stroke | 74 |
Ch. 20 | Hyperlipidemia : primary prevention | 76 |
Ch. 21 | Hyperlipidemia : secondary prevention | 79 |
Ch. 22 | Peripheral vascular disease | 81 |
Ch. 23 | Hypovolemic shock | 83 |
Ch. 24 | Acute asthma | 87 |
Ch. 25 | Chronic asthma | 90 |
Ch. 26 | Chronic obstructive lung disease | 93 |
Ch. 27 | Cystic fibrosis | 95 |
Ch. 28 | Gastroesophageal reflux disease | 99 |
Ch. 29 | Peptic ulcer disease | 102 |
Ch. 30 | NSAID-induced ulcer disease | 104 |
Ch. 31 | Stress ulcer prophylaxis/upper GI hemorrhage | 106 |
Ch. 32 | Crohn's disease | 109 |
Ch. 33 | Ulcerative colitis | 111 |
Ch. 34 | Nausea and vomiting | 114 |
Ch. 35 | Diarrhea | 116 |
Ch. 36 | Irritable bowel syndrome | 118 |
Ch. 37 | Pediatric gastroenteritis | 120 |
Ch. 38 | Constipation | 122 |
Ch. 39 | Ascites management in portal hypertension and cirrhosis | 124 |
Ch. 40 | Esophageal varices | 126 |
Ch. 41 | Hepatic encephalopathy | 128 |
Ch. 42 | Acute pancreatitis | 130 |
Ch. 43 | Chronic pancreatitis | 133 |
Ch. 44 | Viral hepatitis A vaccination | 135 |
Ch. 45 | Viral hepatitis B | 137 |
Ch. 46 | Viral hepatitis C | 139 |
Ch. 47 | Drug-induced acute renal failure | 143 |
Ch. 48 | Acute renal failure | 145 |
Ch. 49 | Progressive renal disease | 147 |
Ch. 50 | End-stage renal disease | 149 |
Ch. 51 | Chronic glomerulonephritis | 151 |
Ch. 52 | Syndrome of inappropriate antidiuretic hormone release | 154 |
Ch. 53 | Hyperkalemia, hyperphosphatemia, and hypercalcemia | 156 |
Ch. 54 | Hypercalcemia of malignancy | 158 |
Ch. 55 | Hypokalemia and hypomagnesemia | 161 |
Ch. 56 | Metabolic acidosis | 163 |
Ch. 57 | Metabolic alkalosis | 165 |
Ch. 58 | Multiple sclerosis | 169 |
Ch. 59 | Complex partial seizures | 171 |
Ch. 60 | Generalized tonic-clonic seizures | 173 |
Ch. 61 | Status epilepticus | 175 |
Ch. 62 | Acute management of the brain injury patient | 177 |
Ch. 63 | Parkinson's disease | 179 |
Ch. 64 | Pain management | 181 |
Ch. 65 | Headache disorders | 184 |
Ch. 66 | Attention-deficit hyperactivity disorder | 187 |
Ch. 67 | Eating disorders : anorexia nervosa | 189 |
Ch. 68 | Alzheimer's disease | 191 |
Ch. 69 | Alcohol withdrawal | 193 |
Ch. 70 | Nicotine dependence | 195 |
Ch. 71 | Schizophrenia | 197 |
Ch. 72 | Major depression | 200 |
Ch. 73 | Bipolar disorder | 202 |
Ch. 74 | Generalized anxiety disorder | 205 |
Ch. 75 | Obsessive-compulsive disorder | 208 |
Ch. 76 | Insomnia | 210 |
Ch. 77 | Type 1 diabetes mellitus and ketoacidosis | 213 |
Ch. 78 | Type 2 diabetes mellitus : new onset | 216 |
Ch. 79 | Type 2 diabetes mellitus : existing disease | 218 |
Ch. 80 | Hyperthyroidism : graves' disease | 221 |
Ch. 81 | Hypothyroidism | 223 |
Ch. 82 | Cushing's syndrome | 225 |
Ch. 83 | Addison's disease | 227 |
Ch. 84 | Hyperprolactinemia | 228 |
Ch. 85 | Contraception | 231 |
Ch. 86 | Premenstrual dysphoric disorder | 233 |
Ch. 87 | Managing menopausal symptoms | 236 |
Ch. 88 | Erectile dysfunction | 239 |
Ch. 89 | Benign prostatic hyperplasia | 241 |
Ch. 90 | Neurogenic bladder & urinary incontinence | 244 |
Ch. 91 | Systemic lupus erythematosus | 247 |
Ch. 92 | Solid organ transplantation | 249 |
Ch. 93 | Osteoporosis | 253 |
Ch. 94 | Rheumatoid arthritis | 255 |
Ch. 95 | Osteoarthritis | 257 |
Ch. 96 | Gout and hyperuricemia | 260 |
Ch. 97 | Glaucoma | 263 |
Ch. 98 | Allergic rhinitis | 265 |
Ch. 99 | Acne vulgaris | 269 |
Ch. 100 | Psoriasis | 271 |
Ch. 101 | Atopic dermatitis | 273 |
Ch. 102 | Cutaneous reaction to drugs | 275 |
Ch. 103 | Iron deficiency anemia | 277 |
Ch. 104 | Vitamin B[subscript 12] deficiency | 280 |
Ch. 105 | Folic acid deficiency | 282 |
Ch. 106 | Sickle cell anemia | 284 |
Ch. 107 | Using laboratory tests in infectious disease | 289 |
Ch. 108 | Bacterial meningitis | 291 |
Ch. 109 | Pediatric cough illness/acute bronchitis | 293 |
Ch. 110 | Prevention and treatment of influenza | 295 |
Ch. 111 | Community-acquired pneumonia | 297 |
Ch. 112 | Otitis media | 300 |
Ch. 113 | Streptococcal pharyngitis | 301 |
Ch. 114 | Rhinosinusitis | 303 |
Ch. 115 | Pressure sores | 304 |
Ch. 116 | Diabetic foot infection | 307 |
Ch. 117 | Infective endocarditis | 309 |
Ch. 118 | Pulmonary tuberculosis | 311 |
Ch. 119 | Clostridium difficile-associated diarrhea | 314 |
Ch. 120 | Intra-abdominal infection | 316 |
Ch. 121 | Lower urinary tract infection | 318 |
Ch. 122 | Acute pyelonephritis | 320 |
Ch. 123 | Pelvic inflammatory disease and other sexually-transmitted diseases | 324 |
Ch. 124 | Syphilis | 327 |
Ch. 125 | Genital herpes and chlamydial infections | 328 |
Ch. 126 | Osteomyelitis and septic arthritis | 330 |
Ch. 127 | Gram-negative sepsis | 333 |
Ch. 128 | Dermatophytosis | 335 |
Ch. 129 | Bacterial vaginosis | 337 |
Ch. 130 | Candida vaginitis | 339 |
Ch. 131 | Systemic fungal infection | 341 |
Ch. 132 | Infections in immunocompromised patients | 344 |
Ch. 133 | Antimicrobial prophylaxis for surgery | 346 |
Ch. 134 | Pediatric immunization | 348 |
Ch. 135 | Adult immunization | 350 |
Ch. 136 | Cytomegalovirus (CMV) retinitis | 352 |
Ch. 137 | HIV infection | 354 |
Ch. 138 | HIV and hepatitis C coinfection | 357 |
Ch. 139 | Breast cancer | 361 |
Ch. 140 | Non-small cell lung cancer | 364 |
Ch. 141 | Colon cancer | 367 |
Ch. 142 | Prostate cancer | 369 |
Ch. 143 | Non-Hodgkin's lymphoma | 371 |
Ch. 144 | Hodgkin's disease | 373 |
Ch. 145 | Ovarian cancer | 376 |
Ch. 146 | Acute lymphocytic leukemia | 378 |
Ch. 147 | Chronic myelogenous leukemia | 382 |
Ch. 148 | Melanoma | 384 |
Ch. 149 | Hematopoietic stem cell transplantation | 386 |
Ch. 150 | Parenteral nutrition | 391 |
Ch. 151 | Adult enteral nutrition | 394 |
Ch. 152 | Obesity | 397 |
Ch. 153 | Chemical exposure | 401 |